HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intrauterine therapy for fetal supraventricular tachycardia in a twin pregnancy.

Abstract
A case of a twin pregnancy in which one fetus developed hydrops secondary to supraventricular tachycardia was detected at 21 weeks' gestation. Transplacental digoxin therapy successfully converted the supraventricular tachycardia to a normal sinus rhythm without evidence of maternal or fetal side-effects. The pregnancy proceeded to term and elective cesarean section was carried out at 37 weeks' gestation.
AuthorsSomchai Tanawattanacharoen, Boonchai Uerpairojkit, Somchai Prechawat, Saknan Manotaya, Dhiraphongs Charoenvidhya
JournalThe journal of obstetrics and gynaecology research (J Obstet Gynaecol Res) Vol. 31 Issue 2 Pg. 94-7 (Apr 2005) ISSN: 1341-8076 [Print] Australia
PMID15771633 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Digoxin
Topics
  • Adult
  • Cesarean Section
  • Digoxin (therapeutic use)
  • Diseases in Twins
  • Fatal Outcome
  • Female
  • Fetal Diseases (diagnosis, drug therapy)
  • Gestational Age
  • Humans
  • Hydrops Fetalis (complications, diagnostic imaging)
  • Male
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy, Multiple
  • Tachycardia, Supraventricular (diagnosis, drug therapy)
  • Ultrasonography, Prenatal

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: